30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

U.K.'s NICE Maintains Recommendation for Bioventus' EXOGEN -

The National Institute for Health and Clinical Excellence in the U.K. updated its guidance regarding use of Bioventus' EXOGEN® Ultrasound Bone Healing System to treat long bone fractures. NICE originally made its recommendation for EXOGEN in 2013. External assessment found that while the cost of revision surgery has increased 25%, costs related to the use of EXOGEN to treat long bone fractures with nonunion has remained the same since previous review in 2013. This has resulted in the doubling of cost savings to £2,407 (~USD $3,000, previously £1,164/$1,400) per patient by avoiding surgery. EXOGEN uses low-intensity pulsed ultrasound to stimulate the natural bone healing process and promote fracture healing. It has demonstrated an 86% heal rate for fractures that have not healed on their own, and may provide 38% faster healing of fresh fractures. (Bioventus, 10/8/19)